Characteristics | |
---|---|
Age (years), median (range) | 49 (20–81) |
Gender, n (%) | |
M | 26 (39) |
F | 41 (61) |
Clinical phenotype, n (%) | |
Classic | 17 (25) |
Non-classic | 50 (75) |
Treatment status, n (%) | |
Enzyme replacement therapy | 28 (42) |
Oral chaperone | 21 (31) |
Other treatment | 1 (2) |
No on Fabry-specific treatments | 17 (25) |